Dr. Hwang on the Addition of Radium-223 to Abiraterone Acetate and Prednisone in mCRPC
May 5th 2020Clara Hwang, MD, discusses the phase 3 ERA-223 trial evaluating the addition of radium-223 dichloride to abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer and bone metastases.
Read More